Basic leucine zipper and W2 domains 1 pseudogene 2 (BZW1P2)

Basic leucine zipper and W2 domains 1 pseudogene 2 (BZW1P2) is a pseudogene—a DNA sequence similar to a protein-coding gene (BZW1), but generally predicted to be nonfunctional as a protein due to sequence disruptions such as premature stop codons or frameshifts[6][3]. Like other pseudogenes, BZW1P2 does not encode a functional protein and is not considered a conventional molecular target such as a receptor or enzyme[3][6]. Recent research suggests some pseudogenes can regulate gene expression post-transcriptionally, often through acting as “sponges” for microRNAs (miRNAs) and possibly modulating the function of their parental genes (in this case, BZW1)[2][4][5]. BZW1P2 is among pseudogenes found to be differentially expressed in certain neurodegenerative diseases, possibly affecting disease processes through RNA-mediated mechanisms[2], but there is no evidence of direct involvement as a therapeutic target, nor are there known drugs targeting it or established roles as a disease biomarker. Key points: Pseudogene (noncoding DNA sequence, similar to but not functioning as its parent gene[6][3]). Not a direct therapeutic target (not a receptor, enzyme, transporter, transcription factor, or protein drug target). Possible post-transcriptional regulatory functions via noncoding RNA, but evidence for direct, specific biological or disease-modifying functions is still evolving and sometimes controversial[4][5]. No established drugs, biomarkers, or safety concerns relevant to clinical practice. There is nothing inherently misspelled in the target name, but BZW1P2 is not an actionable molecule/receptor and should generally not be treated as a conventional drug target or therapeutic entry.

Other names

BZW1P2Basic leucine zipper and W2 domains 1 pseudogene 2

Not applicable; not a protein or drug target